& of course, for those who have the time, I highly recommend reading the full paper, here: doi.org/10.1016/j.ajcn…
But for those who prefer video or TW thread... HERE WE GO...
3/18) What the researchers did in this paper is perform a secondary analysis of pre-existing data from a 12-month RCT: the DIETFITS trial in which 609 adults aged 18-50 without diabetes were randomized to either a 12 m Low-carb diet (LCD) or low-fa diet (LFD).
4/18) Initial data showed LCD led to more weight loss than LFD at 3 and 6 mo, but that the between group diff in weight loss lost significance at 12 months
This was taken to be evidence against the CIM. However, as this paper reveals, there is more nuance to the story...
5/18) One important ? is why significance was lost at 12mo?
2 reasons...
i) Participant dropout. Each group lost ~80 participants, diminishing statistic power
AND
ii) Diet convergence: ‘Carb creep’ in the LCD group (132g/d) + carb drop in the LFD group (213g/d)
6/18) Even setting aside the dietary convergence, when missing data was imputed, the LCD group did in fact lose more weight at 12 m than the LFD group at all time points.
7/18) Moving on, Fig 2 shows a model of predictors of weight loss ➡️ larger circumferences represent better predictors of weight loss
🍽️🍽️Total fat & Calories were poorer predictors of weight loss
🍩🥭Carbs & GI and sugar are the superior predictors
Consistent with the CIM
8/18) In Table are 2 models examining the mediators of weight loss
When you add in Glycemic Load (GL) is added to the model in model 2, GL is highly significant (p=5.7x10-5) and calories (p=0.80) LOSE significance!
Let’s expand on this point...
9/18) Many think that LCD works bc it just makes you eat fewer calories, but that it’s actually the drop in calorie intake that’s driving the weight loss. This certainly is a contributing factor but...
10/18) These results show that GL is better than caloric intake at predicting weight loss, which may appear counterintuitive BUT can be made intuitive if you think about the components of Energy balance: Calories in & Calories out...
11/18) The CICO model, when taken in CLINICAL practice, usually focuses on CI because accurately measuring CO accurately is next to impossible (think, NEAT, TEF, body temp, etc.)
12/18) By contrast, if GL influences the hormonal milieu of the body, it dictates NOT ONLY hunger and caloric intake (CI) but also homeostatic mechanisms to maintain energy equilibrium, or tip it one way or another, through CO: NEAT, body temp, etc.
13/18) Simply put, one could actually make the argument that the CIM is actually a superior real-life ‘CICO’ model than the standard cal counting CICO model itself!
LOL If that doesn’t make sense, read ^ again and watch video for completeness
14/18) Other cool data presented in this paper consistent with the results already shared is that, in fig 5, a biomarker of low-carb/GL (TG/HDL) was strongly associated with weight loss whereas a biomarker of fat reduction (LDL+HDL) was not.
15/18) Finally, and beautifully, the authors put a bold prediction of the CIM to the test which is that those with higher basal insulin secretion would benefit most for GL reduction. Again, this is b/c in the CIM GL influences insulin to cause fat storage.
16/18) So, if someone naturally is an insulin hyper-secreter, the effect of the model is simply going to be amplified. As a result, those who secrete a lot of insulin probably benefit the most from reducing GL. Is that the case? As it turns out yes!
17/18) Clearly see an interaction b/w GL reduction and basal insulin
As you can see in the back left row, these persons who reduced GL most and were the insulin hyper secreters, lost the most weight!
18/18) In summary, this paper provides powerful evidence for two prediction of the CIM: (1) GL > Calories as a predictor of weight loss and (2) insulin hyper secreters benefit most from carb reduction.
(1/8) Alzheimer’s disease is personal for me. In my early 20s, I discovered I carry the ApoE4/4 genotype—placing me at the highest genetic risk. I was terrified. But over time, that fear shifted to a realization:
👉A genetic predisposition is a vulnerability, not a destiny.
👉 Our choices shape our health trajectory more than our genes ever could.
Today, I want to share a piece of that puzzle: The Omega-3 Paradox.
👉The Signal: Data clearly shows eating fatty fish lowers Alzheimer’s rates and boosts cognitive longevity.
👉The Failure: Yet, large clinical trials using Omega-3 supplements often fail to protect the brain.
👉The Question: Why?
One answer lies in a specific delivery mechanism most people—and many researchers—overlook.
Here is the science of getting Omega-3s into the brain. 🧵👇
(2/8) So, why do supplements often miss the mark? The answer is likely the form in which the Omega-3s are packaged.
When you eat seafood, you ingest Omega-3s in diverse forms, including phospholipids. However, most supplements on the shelf provide them in other forms, like triglycerides.
The Form Matters…
(3/8) The Form of Omega-3 Matters.
Think of it like this: Consuming DHA as a free fatty acid triglyceride is like mailing a letter with no address. It enters your system, but it doesn't know where to go. It rarely reaches the brain.
But if you have phospholipid-bound DHA? That’s like sending a letter via express courier, straight to the correct neuron. More specifically, the “express courier” form is called Lyso-DHA.
This specific form has special access to the brain through a transporter called MFSD2A.
Without the phospholipid "address," the DHA gets lost in transit.
How Metabolic Disease Feeds Emotional Eating 🧠🍩
(link at the end)
1/8) A brand new study (Dec 10, 2025) reveals how poor metabolic health can drive emotional eating.
Why this is important: There’s a known link between metabolic disease (obesity, diabetes, etc.) and mental health conditions (eating disorders, anxiety, depression).
But the causal relationships remain murky.
In uncovering the “how” we lay the groundwork for innovative solutions.
cc @Metabolic_Mind @janellison @TuitNutrition @ChrisPalmerMD @MitoPsychoBio @WilliamFurness @drjenunwin
2/8) The researchers behind the experiments took interest in ImP, which is known to be elevated in patients with metabolic conditions like diabetes (below)—and is linked to cardiometabolic disease.
*ImP levels are elevated in humans with type 2 diabetes (red) vs healthy controls (blue).
3/8) Given the link between metabolic diseases and mental health, the researchers set out to test a new hypothesis:
If you increase ImP, does that change the brain and behavior?
To do this, they fitted mice with a tiny pump that continuously delivered ImP at levels designed to mimic what’s seen in people with diabetes.
Afterward, they looked for neural changes and found a large shift in gene-expression programs within neurons tied to the stress response in the hypothalamus.
When The “Cholesterol Drop” Misses the Mark
(Links in 6/7 and 7/7)
1/7) Can we assume that how much LDL drops tells us how much cardiovascular risk is reduced?
A new meta-analysis in the European Heart Journal says, “No.”
In fact, it suggests the link between LDL-C reduction and actual cardiovascular outcomes is incredibly weak.
So, have we built a multi-billion-dollar industry on the assumption that hot chocolate equals real illness?
Let’s unpack that…
cc @realDaveFeldman @AdrianSotoMota @ApoDudz @DrEricRodgers @LDLSkeptic @AKoutnik @janellison @bschermd
2/7) This was an umbrella review of meta-analyses of randomized controlled trials.
In total, the review included 20 RCTs comprising 194,686 participants, with a median follow-up of 4.85 years.
So, what did they find?
In this study, the r² for LDL-C on major adverse cardiovascular events ranged from 0 to 0.1.
In other words, this calls into serious question whether LDL-C can be used as a surrogate for clinical outcomes in statin trials.
3/7) To better define r2 (pronounced “R-squared”)… it’s a number that tells you how well one thing predicts another. It ranges from 0 to 1 (or 0% to 100%):
r² = 1 means perfect prediction — knowing the first number tells you exactly what the second will be.
r² = 0 means no prediction — the first number tells you nothing about the second.
r² <0.1 ... is terrible!
It’s like trying to predict who will win the marathon based on who tied their shoes the tightest.
🚨How Berberine Lowers Cholesterol: Blew My Mind! (link at the end)
1/6) I just learned how berberine lowers LDL-C/ApoB, and the *mechanism* blew my mind.
Unlike statins, it doesn’t inhibit cholesterol synthesis, or harm mitochondria, and doesn’t worsen insulin resistance.
In fact, it improves features of metabolic health, while also lowering LDL and ApoB in a totally unexpected way.
Let’s break it down...
⚠️ Warning: This is a heart-health nerd's only zone. Proceed at your own risk, especially with 4/6.
@ApoDudz @lipo_fan @realDaveFeldman @AdrianSotoMota @LDLSkeptic @AKoutnik @janellison @bschermd @tyler_smith @Hundredhealth @DrPaulMason @robbwolf @reallyoptimized
2/6) First, contrast with statins. Statins inhibit cholesterol synthesis, creating a relative “cholesterol starvation” state in liver cells.
The liver compensates by ramping up LDL receptor expression, which pulls LDL particles out of the bloodstream. Effective—but not without tradeoffs, which can include off-target effects in other organs:
1/6) If you’ve ever thought, “What if I just reset my microbiome?” Well, that’s what I want to help you do today.
But why even ask this question?
Let me back up—about 29 years—and share a bit of personal context.
As a newborn, I spiked a fever of 106°F. Out of caution, I was given powerful antibiotics.
Today, we better understand how critical early life is for microbiome development. Antibiotics like the ones I received can leave a lasting scar—even increasing risk for inflammatory bowel disease (IBD) later in life by ~500%.
Lo and behold, I did develop IBD—specifically, ulcerative colitis. It nearly killed me.
2/6) The truth is, our microbiomes are under constant assault—sabotaged daily by the booby traps of modern living.
From the moment you wake up and pour cereal into a bowl to the moment you collapse into bed, eyes glazed from “just one more” episode, our environments have drifted so far from nature’s blueprint that most of our microbiomes are evolutionarily unrecognizable.
So, what might a microbiome reset look like?
3/6) In today’s letter, we push the boundaries of science (and colon walls). We discuss:
👉A Step-by Step 4-Phase Guide
👉What to Avoid when you’re in microbiome in maintenance mode
👉Lifestyle inputs Beyond Food that shape your gut health. staycuriousmetabolism.substack.com/p/how-im-rebui…
1/5)The results were... surprising 😳
👉Body fat (7%)
👉Omega-3 levels, off the chart (literally, 25% higher than the visual scale goes and 2.7% above reference range)
👉Energy = Excellent (after some tweaks)
👉Cold Resistant. Maybe an impact of omega-3 on thermogenesis (via omega-3 derivatives, e.g. 12-HEPE)
2/5) The Rationale: Sardines are about as close to a superfood as one can get: packed with protein, omega-3, calcium, B12, CoQ10, creatine, etc.
They're like if a multivitamin had a baby with a protein supplement - but natural. So you can pretty much live off sardines
3/5) For the first several days I did only sardines. But then my energy dipped. So I adapted my 'sardine fast' into a sardine-based diet, supplementing with added fat - especially olive oil and MCTs.
This turned me into an energizer bunny and made the Sardine Diet sustainable for a full month.